Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

73.1K
Overview
73.1K
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

6.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

4.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Whole-genome doubling drives immune evasion by silencing antigen presentation.

Cancer cell·2026
Same author

Targeting the p53 pathway to treat atypical teratoid rhabdoid tumors.

Neuro-oncology pediatrics·2026
Same author

A glucocorticoid-FAS axis controls immune evasion during metastatic seeding.

Nature·2026
Same author

Stress-induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity.

Cell·2025
Same author

Nisin, a promising antimicrobial peptide, forestalls the methicillin-resistant <i>Staphylococcus aureus</i> biofilm network via reactive oxygen species generation.

3 Biotech·2025
Same author

Decoding the spatial dynamics of tumor and immune cell interactions in solid cancers.

Cancer cell·2025

相关实验视频

Updated: Sep 14, 2025

Bone Conditioned Medium: Preparation and Bioassay
07:18

Bone Conditioned Medium: Preparation and Bioassay

Published on: July 8, 2015

11.2K

骨食欲:来自骨的因素为远程的免疫抑制提供食物.

Debolina Ganguly1, Judith Agudo2

  • 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02215, USA; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Trends in cancer
|July 18, 2025
PubMed
概括

骨转移会损害免疫系统,阻碍免疫治疗的有效性. 由骨瘤产生的骨质素抑制远部位的免疫力,揭示了癌症免疫逃避的新机制.

关键词:
免疫疗法 免疫疗法器官交叉的交叉体质是什么系统因素是系统因素.

更多相关视频

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.4K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

相关实验视频

Last Updated: Sep 14, 2025

Bone Conditioned Medium: Preparation and Bioassay
07:18

Bone Conditioned Medium: Preparation and Bioassay

Published on: July 8, 2015

11.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.4K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 癌症转移 癌症转移

背景情况:

  • 转移性癌症的位置显著影响治疗结果.
  • 了解转移的系统性影响对于有效的癌症治疗至关重要.

研究的目的:

  • 研究骨转移如何影响系统免疫功能.
  • 确定骨转移阻碍免疫疗法反应的机制.

主要方法:

  • 分析了一项由Cheng等人进行的研究. 在癌细胞中.
  • 在骨转移的背景下检查免疫功能.

主要成果:

  • 发现骨转移会导致免疫功能系统性下降.
  • 通过骨转移产生的骨质素 (OPN) 被确定为远距离病变中抑制免疫力的关键因素.
  • 这表明一种新的跨器官通讯途径会损害抗瘤免疫力.

结论:

  • 骨转移会产生一种免疫抑制的环境,限制免疫疗法的有效性.
  • 向osteopontin或相关途径可能会恢复免疫功能并改善癌症治疗结果.